A detailed history of Geode Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 12,019,038 shares of AMGN stock, worth $3.84 Billion. This represents 0.33% of its overall portfolio holdings.

Number of Shares
12,019,038
Previous 11,643,308 3.23%
Holding current value
$3.84 Billion
Previous $3.31 Billion 13.44%
% of portfolio
0.33%
Previous 0.31%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$262.75 - $319.31 $98.7 Million - $120 Million
375,730 Added 3.23%
12,019,038 $3.76 Billion
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $187 Million - $226 Million
-696,648 Reduced 5.65%
11,643,308 $3.31 Billion
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $51.8 Million - $58.4 Million
202,465 Added 1.67%
12,339,956 $3.55 Billion
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $74 Million - $91.8 Million
338,308 Added 2.87%
12,137,491 $3.26 Billion
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $79 Million - $93.5 Million
368,924 Added 3.23%
11,799,183 $2.62 Billion
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $12.3 Million - $15.1 Million
54,692 Added 0.48%
11,430,259 $2.76 Billion
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $40 Million - $50.9 Million
174,774 Added 1.56%
11,375,567 $2.98 Billion
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $113 Million - $127 Million
502,787 Added 4.7%
11,200,793 $2.52 Billion
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $23.2 Million - $25.8 Million
-100,505 Reduced 0.93%
10,698,006 $2.6 Billion
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $125 Million - $138 Million
570,720 Added 5.58%
10,798,511 $2.61 Billion
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $26.7 Million - $30.6 Million
-134,319 Reduced 1.3%
10,227,791 $2.3 Billion
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $78.1 Million - $91.5 Million
367,936 Added 3.68%
10,362,110 $2.2 Billion
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $73.3 Million - $81.3 Million
313,744 Added 3.24%
9,994,174 $2.43 Billion
Q1 2021

May 12, 2021

BUY
$221.91 - $258.6 $195 Million - $227 Million
879,184 Added 9.99%
9,680,430 $2.4 Billion
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $80.3 Million - $95.6 Million
-371,068 Reduced 4.05%
8,801,246 $2.02 Billion
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $201 Million - $224 Million
-857,163 Reduced 8.55%
9,172,314 $2.33 Billion
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $17.4 Million - $21.3 Million
-87,724 Reduced 0.87%
10,029,477 $2.36 Billion
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $16 Million - $21.3 Million
88,020 Added 0.88%
10,117,201 $2.05 Billion
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $19.6 Million - $25.2 Million
103,548 Added 1.04%
10,029,181 $2.41 Billion
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $24.5 Million - $29.4 Million
140,880 Added 1.44%
9,925,633 $1.92 Billion
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $22.2 Million - $26.1 Million
133,399 Added 1.38%
9,784,753 $1.8 Billion
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $145 Million - $163 Million
801,130 Added 9.05%
9,651,354 $1.83 Billion
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $86.1 Million - $101 Million
482,760 Added 5.77%
8,850,224 $1.72 Billion
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $14.9 Million - $16.7 Million
-80,177 Reduced 0.95%
8,367,464 $1.73 Billion
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $55.5 Million - $62.3 Million
333,939 Added 4.12%
8,447,641 $1.56 Billion
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $604,695 - $706,662
3,569 Added 0.04%
8,113,702 $1.38 Billion
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $33.7 Million - $37.7 Million
199,838 Added 2.53%
8,110,133 $1.41 Billion
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $9.91 Million - $11.3 Million
59,263 Added 0.75%
7,910,295 $1.47 Billion
Q2 2017

Aug 14, 2017

BUY
N/A
7,851,032
7,851,032 $1.35 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.